Atropisomeric Amides as Chiral Ligands
J . Org. Chem., Vol. 65, No. 21, 2000 7039
) 11.0 Hz), 133.8 (d, J ) 15.5 Hz), 133.3 (d, J ) 19.0 Hz),
133.2 (d, J ) 19.5 Hz), 130.6 (d, J ) 2.0 Hz), 128.3 (d, J ) 6.0
Hz), 128.1 (d, J ) 4.0 Hz), 128.0 (d, J ) 6.5 Hz), 127.7, 126.8,
50.3, 45.8, 25.3, 21.1, 20.8 (d, J ) 6.0 Hz), 20.4, 20.0 (d, J )
2.0 Hz), 16.1, -2.8; MS (CI) m/z (rel intensity) 490 (MH+, 100),
306 (35) 187 (70); HRMS (EI) calcd for C30H40NOPSi (M+)
1). Anal. Calcd for C16H25NO: C, 77.68; H, 10.19; N, 5.66.
Found: C, 77.76; H, 10.47; N, 5.72.
The 1H NMR spectrum of this material in the presence of
(+)-2,2,2-trifluoro-1-(9-anthryl)ethanol (TFAE)22 showed an
Ar-Me signal originating from the minor enantiomer of
comparable size to the 13C-coupled side-peaks of the Ar-Me
signal of the major enantiomer, from which we deduce an ee
of >98%. Addition of (()-9b to the sample of (+)-9b proved
the identity of this minor peak.
489.2617, found 489.2622 (1.1 ppm); [R]23 -44.0 (CHCl3, c )
D
2.68). Anal. Calcd for C30H40NOPSi: C, 73.58; H, 8.23; N, 2.86;
P, 6.32. Found: C, 73.46; H, 8.29; N, 2.70; P, 6.32.
(Sa )-N,N-Diisop r op yl-2-et h yl-6-d ip h en ylp h osp h on yl-
ben za m id e 9c. Silylated benzamide 8c (170 mg) was treated
with TBAF according to the general procedure. Purification
of the crude product by column chromatography (eluting with
petrol/EtOAc 3:1 at ca. 0-5 °C) gave the title compound 9c
(144 mg, 99%), as a white foam: Rf(petrol/EtOAc) 0.40; IR
(S ,S a )-N ,N -Diisop r op yl-2-(1-t r im e t h ylsilyle t h yl)-6-
p h en ylsu lfa n ylben za m id e 8e. In the same way, benzamide
5 (76 mg) and diphenyl disulfide (55 mg, 1.5 equiv, as a
solution in 2 mL of THF) gave a waxy crude product that was
purified by column chromatography (eluting with petrol/EtOAc
19:1) to give the title compound 8e (90 mg, 87%) as a white
solid: mp 140-142 °C; Rf(petrol/EtOAc 19:1) 0.27; IR (film/
CHCl3) 2960, 1631, cm-1; 1H NMR (CDCl3, 300 MHz) δ 7.10-
7.36 (6H, m), 7.00 (1H, dd, J ) 1, 8 Hz), 6.95 (1H, dd, J ) 1,
8 Hz), 3.72 (1H, sept, J ) 6.5 Hz), 3.51 (1H, sept, J ) 6.5 Hz),
2.21 (1H, q, J ) 7.5 Hz), 1.60 (3H, d, J ) 6.5 Hz), 1.57 (3H, d,
J ) 6.5 Hz), 1.35 (3H, d, J ) 7.5 Hz), 1.19 (3H, d, J ) 6.5 Hz),
1.13 (3H, d, J ) 6.5 Hz), 0.00 (9H, s); 1H NMR (CDCl3, 75 MHz)
δ 168.0, 143.9, 138.4, 136.1, 132.3, 131.0, 128.9, 128.2, 128.1,
126.8, 124.9, 50.4, 45.8, 25.6, 21.0, 20.8, 20.3, 20.1, 16.3, -2.8;
MS (CI) m/z 414 (MH+, 100); HRMS (EI) calcd for C24H35NOSSi
(M+) 413.2209, found 413.2223 (3.5 ppm); [R]23D -28.4 (CHCl3,
c ) 1). Anal. Calcd for C24H35NOSSi: C, 69.68; H, 8.53; N,
3.39; S, 7.75. Found: C, 69.65; H, 8.84; N, 3.43; S, 7.92.
Desilyla tion of Ben za m id es 8. TBAF (1 M solution in
THF, 10 equiv) was added to a solution of the silylated amide
8 in THF (0.02M) at room temperature. The resulting solution
was stirred for 5 min, then poured into cold water and
extracted into ether. The combined extracts were dried (Mg-
SO4) and concentrated under reduced pressure at <20 °C to
give the crude products, which were purified by column
chromatography (fractions kept at ca. 0-5 °C), to give the
desilylated products 9.
(film/CHCl3) 2975, 2929, 1630 cm-1 1H NMR (CDCl3, 300
;
MHz) δ 7.59-7.67 (4H, m), 7.38-7.55 (7H, m), 7.23 (1H, dt, J
) 3.0, 8.0 Hz), 7.00 (1H, ddd, J ) 1.0, 7.5, 13.5 Hz), 3.68 (1H,
sept, J ) 7.0 Hz), 3.50 (1H, sept, J ) 7.0 Hz), 2.80 (1H, dq, J
) 15, 7.5 Hz), 2.65 (1H, dq, J ) 15, 7.5 Hz), 1.55, (3H, d, J )
7.0 Hz), 1.51 (3H, d, J ) 7.0 Hz), 1.36 (3H, d, J ) 6.5 Hz),
1.25 (3H, t, J ) 7.5 Hz), 1.10 (3H, d, J ) 6.5 Hz); 13C NMR
(CDCl3, 75 MHz) δ 167.6 (d, J ) 3.5 Hz), 142.1 (d, J ) 8.0
Hz), 141.4 (d, J ) 10.0 Hz), 134.1 (d, J ) 103.0 Hz), 132.9 (d,
J ) 108.0 Hz), 132.2 (d, J ) 9.0 Hz), 131.9 (d, J ) 9.0 Hz),
131.8 (d, J ) 5.5 Hz), 131.5 (d, J ) 3.0 Hz), 131.5 (d, J ) 2.0
Hz), 131.0 (d, J ) 13.0 Hz), 128.3 (d, J ) 12.0 Hz), 128.1 (d, J
) 101.5 Hz), 128.1 (d, J ) 13.0 Hz), 126.9 (d, J ) 13.5 Hz),
51.0, 45.9, 25.1, 20.9, 20.3, 19.9, 19.7, 14.9; MS (EI) m/z (rel
intensity) 434 (MH+, 100), 333 (20) 100 (42); HRMS (EI) calcd
for C27H32NO2P (M+) 433.2171, found 433.2175 (1.0 ppm);
23
[R]D +18.0 (CHCl3, c ) 1.6). Anal. Calcd for C27H32NO2P: C,
74.80; H, 7.44; N, 3.23; P, 7.14. Found: C, 74.56; H, 7.61; N,
3.05; P, 6.83.
(Sa )-N,N-Diisop r op yl-2-et h yl-6-d ip h en ylp h osp h in yl-
ben za m id e 9d . Silylated benzamide 8d (112 mg) was treated
with TBAF according to the general procedure. Purification
of the crude product by column chromatography (eluting with
petrol/EtOAc 9:1 at ca. 0-5 °C) gave the title compound 9d
(82 mg, 86%) as white solid: mp 129-130 °C; Rf(petrol/EtOAc
(Sa )-N,N-Diisop r op yl-2-et h yl-6-(1-h yd r oxy-1-m et h yl)-
eth ylben za m id e 9a . Silylated benzamide 8a (35 mg) was
treated with TBAF according to the general procedure. Puri-
fication of the crude product by column chromatography
(eluting with petrol/EtOAc 9:1 at ca. 0-5 °C) gave the title
compound 9a (28 mg, 99%) as a white solid: mp 96-98 °C;
Rf(petrol/EtOAc 4:1) 0.17; IR (film/CHCl3) 3415, 2975, 2932,
1
4:1) 0.46; IR (film/CHCl3) 2969, 1628 cm-1; H NMR (CDCl3,
300 MHz) δ 7.22-7.38 (12H, m), 7.05 (1 H, ddd, J ) 1, 3.5,
7.5 Hz), 3.80 (1H, sept, J ) 6.5 Hz), 3.59 (1H, sept, J ) 6.5
Hz), 2.81 (1H, dq, J ) 15, 7.5 Hz), 2.67 (1H, dq, J ) 15, 7.5
Hz), 1.70 (3H, d, J ) 6.5 Hz), 1.63 (3H, d, J ) 6.5 Hz), 1.32
(3H, d, J ) 7.5 Hz), 1.24 (3H, d, J ) 6.5 Hz), 1.18 (3H, d, J )
6.5 Hz); 13C NMR (CDCl3, 75 MHz) δ 168.9 (d, J ) 5.0 Hz),
144.5 (d, J ) 36.5 Hz), 139.6 (d, J ) 8.5 Hz), 138.1 (d, J )
11.5 Hz), 137.0 (d, J ) 11.5 Hz), 133.6 (d, J ) 15.5 Hz), 133.4
(d, J ) 19.5 Hz), 133.1 (d, J ) 19.0 Hz), 132.1 (d, J ) 2.5 Hz),
129.0, 128.3, 128.3 (d, J ) 5.5 Hz), 128.2 (d, J ) 7.5 Hz), 128.0,
127.8, 21.0, 20.8 (d, J ) 6.0 Hz), 20.5, 20.1 (d, J ) 2.0 Hz),
14.7; MS (EI) m/z (rel intensity) 418 (MH+, 10 - self-CI), 417
(M+, 8), 374 (50), 332 (100); HRMS (EI) calcd for C27H32NOP
1
2874, 1609 cm-1; H NMR (CDCl3, 300 MHz) δ 7.22 (1H, t, J
) 8 Hz), 7.12 (1H, d, J ) 7 Hz), 7.07 (1H, d, J ) 8 Hz), 3.61
(1H, sept, J ) 7.5 Hz), 3.50 (1H, sept, J ) 6.5 Hz), 2.85 (1H,
br s), 2.75 (1H, dq, J ) 15, 7.5 Hz), 2.58 (1H, dq, J ) 15, 7.5
Hz), 1.60 (3H, s), 1.57 (3H, s), 1.57 (3H, d, J ) 6.5 Hz), 1.56
(3H, d, J ) 6.5 Hz), 1.22 (3H, t, J ) 7.5 Hz), 1.16 (3H, d, J )
6.5 Hz), 1.09 (3H, d, J ) 6.5 Hz); 13C NMR (CDCl3, 75 MHz)
δ 173.0, 145.4, 140.1, 133.5, 127.6, 126.4, 124.7, 74.5, 50.9, 45.7,
34.7, 31.2, 25.3, 20.2, 20.1, 19.5, 15.3; MS (CI) m/z (rel
intensity) 292 (MH+, 100), 274 (20); HRMS (CI) calcd for
(M+) 417.2221, found 417.2218 (0.7 ppm); [R]D -4.0 (CHCl3,
23
C18H30NO2 (MH+) 292.2276, found 292.2274 (0.6 ppm); [R]D
23
c ) 1). Anal. Calcd for C27H32NOP: C, 77.67; H, 7.72; N, 3.35;
P, 7.42. Found: C, 77.38; H, 8.05; N, 3.31; P, 7.35.
+32.0 (CHCl3, c ) 1). Anal. Calcd for C18H30NO2: C, 74.18; H,
10.03; N, 4.81. Found: C, 73.83; H, 10.24; N, 4.72.
(Sa )-N,N-Diisop r op yl-2-et h yl-6-p h en ylsu lfa n ylb en za -
m id e 9e. Silylated benzamide 8e (47 mg) was treated with
TBAF according to the general procedure. Purification of the
crude product by column chromatography (eluting with petrol/
EtOAc 9:1 at ca. 0-5 °C) gave the title compound 9e (42 mg,
quantitative) as a white solid: mp 94-95 °C; Rf(petrol/EtOAc
(Ra )-N,N-Diisop r op yl-2-eth yl-6-m eth ylben za m id e 9b.
Silylated benzamide 8b (150 mg) was treated with TBAF
according to the general procedure. Purification of the crude
product by column chromatography (eluting with petrol/EtOAc
9:1 at ca. 0-5 °C) gave the title compound 9b (115 mg, 99%)
as white solid: mp 102-103 °C; Rf(petrol/EtOAc 9:1) 0.49; IR
1
4:1) 0.45; IR (film/CHCl3) 2971, 1630 cm-1; H NMR (CDCl3,
(film/CHCl3) 2629, 2933, 2876, 1621 cm-1 1H NMR (CDCl3,
;
300 MHz) δ 7.51-7.54 (2H, m), 7.37-7.46 (3H, m), 7.27-7.29
(2H, m), 7.14-7.17 (1H, m), 3.83 (1H, sept, J ) 6.5 Hz), 3.67
(1H, sept, J ) 7 Hz), 2.87 (1H, dq, J ) 15, 7.5 Hz), 2.71 (1H,
dq, J ) 15, 7.5 Hz), 1.75 (6H, t, J ) 7 Hz), 1.41 (3H, t, J ) 7.5
Hz), 1.36 (3H, d, J ) 6.5 Hz), 1.25 (3H, d, J ) 6.5 Hz); 13C
NMR (CDCl3, 75 MHz) δ 168.0 (DEPT: quat), 140.6 (quat),
139.3 (quat), 135.5 (quat), 132.3 (quat), 131.5 (CH), 129.2 (CH),
129.0 (CH), 128.3 (CH), 127.0 (CH), 126.7 (CH), 50.9 (CH), 45.9
(CH), 25.6 (CH2), 21.0 (CH3), 20.9 (CH3), 20.5 (CH3), 20.1 (CH3),
14.8 (CH3); MS (CI) m/z (rel intensity) 342 (MH+, 100); HRMS
(EI) calcd for C21H27NOS (M+) 341.1813, found 341.1816 (0.8
300 MHz) δ 7.08 (1H, t, J ) 7.5 Hz), 6.99 (1H, d, J ) 7.5 Hz),
6.93 (1H, d, J ) 7.5 Hz), 3.52 (1H, sept, J ) 6.5 Hz), 3.43 (1H,
sept, J ) 6.5 Hz), 2.57 (1H, dq, J ) 15, 7.5 Hz), 2.46 (1H, dq,
J ) 15, 7.5 Hz), 2.21 (3H, s), 1.52 (3H, d, J ) 6.5 Hz), 1.16
(3H, t, J ) 7.5 Hz), 1.03 (3H, d, J ) 6.5 Hz), 1.01 (3H, d, J )
6.5 Hz); 13C NMR (CDCl3, 75 MHz) δ 170.0, 139.4, 137.5, 133.1,
127.6, 127.5, 125.3, 50.6, 45.7, 25.7, 21.0, 20.4, 20.4, 19.0, 15.1;
MS (EI) m/z (rel intensity) 247 (M+, 10), 232 (15), 218 (15),
204 (10), 147 (100); HRMS (EI) calcd for C16H25NO (M+)
247.1936, found 247.1929 (2.8 ppm); [R]23 +3.2 (CHCl3, c )
D